RemeGen Co., Ltd. (SHA:688331)
China · Delayed Price · Currency is CNY 76.91
+3.13 (4.24%)
Aug 15, 2025, 2:45 PM CST
RemeGen Market Cap
RemeGen has a market cap or net worth of 41.54 billion as of August 15, 2025. Its market cap has increased by 257.60% in one year.
Market Cap
41.54B
Enterprise Value
43.52B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
76.91
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 28.53B to 41.54B, an increase of 45.64%. That is a compound annual growth rate of 8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 41.54B | 215.69% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
| Nov 9, 2020 | 28.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 417.74B |
| WuXi AppTec | 286.10B |
| Shenzhen Mindray Bio-Medical Electronics | 286.01B |
| Sichuan Biokin Pharmaceutical | 126.19B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.00B |
| Aier Eye Hospital Group | 120.01B |
| Shanghai United Imaging Healthcare | 104.90B |
| Yunnan Baiyao Group Co.,Ltd | 99.92B |